New hope for stubborn stomach bug: study tests better antibiotic combo
NCT ID NCT03431688
First seen Oct 31, 2025 · Last updated May 22, 2026 · Updated 29 times
Summary
This study tested two different antibiotic combinations in 782 adults with a hard-to-treat H. pylori infection that is resistant to the common antibiotic clarithromycin. Participants had peptic ulcers, H. pylori-related stomach inflammation, or a low-grade stomach lymphoma. The goal was to see which treatment—a triple therapy or a bismuth-based quadruple therapy—worked better at clearing the infection.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HELICOBACTER PYLORI INFECTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Kangdong Sacred Heart Hospital
Seoul, 134-701, South Korea
Conditions
Explore the condition pages connected to this study.